1570 related articles for article (PubMed ID: 17448976)
1. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
2. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
3. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
Otero-Fernández R; Gómez-Outes A; Martínez-González J; Rocha E; Fontcuberta J;
Clin Appl Thromb Hemost; 2008 Jan; 14(1):75-83. PubMed ID: 17895506
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
[TBL] [Abstract][Full Text] [Related]
6. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
7. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.
Hamad GG; Choban PS
Obes Surg; 2005; 15(10):1368-74. PubMed ID: 16354513
[TBL] [Abstract][Full Text] [Related]
8. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
Peterman CM; Kolansky DM; Spinler SA
Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
[TBL] [Abstract][Full Text] [Related]
10. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil.
Deheinzelin D; Braga AL; Martins LC; Martins MA; Hernandez A; Yoshida WB; Maffei F; Monachini M; Calderaro D; Campos W; Sguizzatto GT; Caramelli B;
J Thromb Haemost; 2006 Jun; 4(6):1266-70. PubMed ID: 16706970
[TBL] [Abstract][Full Text] [Related]
11. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
[TBL] [Abstract][Full Text] [Related]
12. Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study.
Scarpa RM; Carrieri G; Gussoni G; Tubaro A; Conti G; Pagliarulo V; Mirone V; De Lisa A; Fiaccavento G; Cormio L; Bonizzoni E; Agnelli G;
Eur Urol; 2007 Jan; 51(1):130-5; discussion 136. PubMed ID: 16942832
[TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
14. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.
Eriksson BI; Lassen MR;
Arch Intern Med; 2003 Jun; 163(11):1337-42. PubMed ID: 12796070
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis.
Gerber DE; Segal JB; Salhotra A; Olivi A; Grossman SA; Streiff MB
Cancer; 2007 Jan; 109(2):300-5. PubMed ID: 17154163
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolic prophylaxis in hospitalized medical patients.
Stark JE; Kilzer WJ
Ann Pharmacother; 2004 Jan; 38(1):36-40. PubMed ID: 14742790
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?
Koya MP; Manoharan M; Kim SS; Soloway MS
BJU Int; 2005 Nov; 96(7):1019-21. PubMed ID: 16225520
[TBL] [Abstract][Full Text] [Related]
18. Perioperative venous thromboembolism prophylaxis in Israel: a survey of academic surgical departments.
Ellis MH; Elis A
Eur J Haematol; 2004 Aug; 73(2):104-8. PubMed ID: 15245509
[TBL] [Abstract][Full Text] [Related]
19. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows.
Scaglione L; Piobbici M; Pagano E; Ballini L; Tamponi G; Ciccone G
Haematologica; 2005 May; 90(5):678-84. PubMed ID: 15921383
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]